⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCRX News
BioCryst Pharmaceuticals Inc
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCRX
Form 8-K
sec.gov
BCRX
BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema
globenewswire.com
BCRX
Systemic Mastocytosis (SM) Treatment Market 2026-2035: Industry to More Than Double in Size, Led by Sanofi, AdvaCare Pharma, and Cogent Biosciences
globenewswire.com
BCRX
CGNT
NVS
BioCryst to Present at Upcoming Investor Conferences
globenewswire.com
BCRX
MILLROCK TECHNOLOGY APPOINTS NEIL A. GOLDMAN AS CFO
prnewswire.com
BCRX
Form 8-K
sec.gov
TENX
LNSR
BCRX
MRK
GILD
BioCryst to Report First Quarter 2026 Financial Results on May 6
globenewswire.com
BCRX
OncoC4 announces first participant's dosing in Phase 1/2 clinical trial of ONC-841 for the treatment of Alzheimer's disease USA - English APAC - English
prnewswire.com
BCRX
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
globenewswire.com
BCRX